Elsevier

JAAD Case Reports

Volume 6, Issue 3, March 2020, Pages 228-233
JAAD Case Reports

Case series
Increasing evidence for omalizumab in the treatment of bullous pemphigoid

https://doi.org/10.1016/j.jdcr.2020.01.002Get rights and content
Under a Creative Commons license
open access

Key words

autoimmune skin disease
bullous pemphigoid
IgE
omalizumab
steroid sparing

Abbreviations used

BP
Bullous pemphigoid
DIF
Direct immunofluorescence

Cited by (0)

Funding sources: None.

Conflicts of interest: None disclosed.